全基因组关联研究
肾功能
蛋白尿
肾病
疾病
肾脏疾病
荟萃分析
内科学
医学
单核苷酸多态性
遗传关联
生物
生物信息学
遗传学
内分泌学
肾
基因
基因型
糖尿病
作者
Melanie E. Garrett,Karen Soldano,Kyle N. Erwin,Yingze Zhang,Victor R. Gordeuk,Mark T. Gladwin,Marilyn J. Telen,Allison Ashley‐Koch
出处
期刊:Blood Advances
[Elsevier BV]
日期:2023-08-24
卷期号:7 (17): 4782-4793
被引量:1
标识
DOI:10.1182/bloodadvances.2022007451
摘要
Sickle cell disease nephropathy (SCDN), a common SCD complication, is strongly associated with mortality. Polygenic risk scores calculated from recent transethnic meta-analyses of urinary albumin-to-creatinine ratio and estimated glomerular filtration rate (eGFR) trended toward association with proteinuria and eGFR in SCD but the model fit was poor (R2 < 0.01), suggesting that there are likely unique genetic risk factors for SCDN. Therefore, we performed genome-wide association studies (GWAS) for 2 critical manifestations of SCDN, proteinuria and decreased eGFR, in 2 well-characterized adult SCD cohorts, representing, to the best of our knowledge, the largest SCDN sample to date. Meta-analysis identified 6 genome-wide significant associations (false discovery rate, q ≤ 0.05): 3 for proteinuria (CRYL1, VWF, and ADAMTS7) and 3 for eGFR (LRP1B, linc02288, and FPGT-TNNI3K/TNNI3K). These associations are independent of APOL1 risk and represent novel SCDN loci, many with evidence for regulatory function. Moreover, GWAS SNPs in CRYL1, VWF, ADAMTS7, and linc02288 are associated with gene expression in kidney and pathways important to both renal function and SCD biology, supporting the hypothesis that SCDN pathophysiology is distinct from other forms of kidney disease. Together, these findings provide new targets for functional follow-up that could be tested prospectively and potentially used to identify patients with SCD who are at risk, before onset of kidney dysfunction.
科研通智能强力驱动
Strongly Powered by AbleSci AI